https://www.selleckchem.com/pr....oducts/danirixin.htm
5% in the endocarditis following surgical aortic valve replacement group and 9.1% in the endocarditis following transcatheter aortic valve replacement group (p = 0.098). Upon follow-up, survival at 6 months was found to be 98% in the group with endocarditis following surgical aortic valve replacement and 89% in the group with endocarditis following transcatheter aortic valve replacement (p = 0.081). Conclusions Patients suffering from endocarditis following surgical aortic valve replacement and transcatheter aortic valve replacement p
Like
Comment
Share
